Nvidia: BMO Raises Price Target To $750

Nvidia Corp (NASDAQ: NVDA) reported their fiscal third-quarter earnings on May 26th after market close. The company came slightly below the top line analyst estimates, which was $5.661 billion. The company had a gross margin of 64.1% and earnings per share of $3.66.

The companies average 12-month price target from its 43 analysts rose from $669.16 to $703.86, a modest 12% upside after a number of analysts raised their target prices and rating. Nvidia now has 11 analysts with a strong buy rating, 25 with a buy rating, six with a holding rating, and a single analyst with a sell rating. The street high comes in from Rosenblatt with an $800 price target.

BMO Capital Market’s increased their 12-month price target from $680 to $750 off the back of Nvidia’s earnings and reiterated their outperform rating. Their analyst Ambrish Srivastava said that this quarter’s results showed overall strength and that the crypto boom is certainly helping out with sales.

For the earnings, Srivastava writes, “NVIDIA delivered a very strong set of results. Guidance is well above as well,” and commends the companies increased transparency around the impacted data center. He comments that the large increase in inventory purchases makes BMO believe that the strength will continue into the second half of this year.

Nvidia’s revenue came in at $5.66 billion, up 13% quarter over quarter. This beat BMO’s estimates which only called for a 9% quarter-over-quarter rise and PF EPS came in at $3.66 versus their $3.30 estimate. Gross margins came in line with expectations. Gaming sales came in at 49% of the companies total revenue but generally came in line with BMO’s $2.75 billion estimates. Srivastava adds, “While the company is unable to quantify the gaming demand from crypto, it reported $155M in revenues from the new CMP product line.”

Below you can see BMO’s new 2022-2023 full year estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Mindmed: Eight Capital Resumes Coverage With $6.50 Price Target

Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes...

Friday, September 17, 2021, 03:23:00 PM

Canaccord Reiterates $1.75 Price Target For Mind Medicine Following Roadshow Event

This morning, Canaccord released a flash update for Mind Medicine (NEO: MMED) with highlights from...

Monday, September 28, 2020, 11:02:24 AM

BMO Cuts Price Target On Salesforce On Disappointing Guidance

Salesforce (NYSE: CRM) last week reported it’s third-quarter financial results for the period ending October...

Wednesday, December 7, 2022, 03:50:00 PM

Yamana Gold: Stifel, Canaccord Issue Flash Update Following Preliminary Results

This morning Canaccord Genuity and Stifel GMP released a flash update on Yamana Gold (TSX:...

Thursday, October 8, 2020, 01:13:00 PM

Tilray: Canaccord Reiterates US$12 Price Target After Distillery Purchase

On December 8th, Tilray (TSX: TLRY) announced the acquisition of Breckenridge Distillery, a whiskey and...

Friday, December 10, 2021, 03:39:00 PM